194 related articles for article (PubMed ID: 22715368)
41. Selective downregulation of natural killer activating receptors on NK cells and upregulation of PD-1 expression on T cells in children with severe and/or recurrent Herpes simplex virus infections.
Lenart M; Kluczewska A; Szaflarska A; Rutkowska-Zapała M; Wąsik M; Ziemiańska-Pięta A; Kobylarz K; Pituch-Noworolska A; Siedlar M
Immunobiology; 2021 May; 226(3):152097. PubMed ID: 34015527
[TBL] [Abstract][Full Text] [Related]
42. Regulation of self-ligands for activating natural killer cell receptors.
Lam RA; Chwee JY; Le Bert N; Sauer M; Pogge von Strandmann E; Gasser S
Ann Med; 2013 Jun; 45(4):384-94. PubMed ID: 23701136
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
44. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation.
Schierloh P; Alemán M; Yokobori N; Alves L; Roldán N; Abbate E; del C Sasiain M; de la Barrera S
Immunology; 2005 Dec; 116(4):541-52. PubMed ID: 16313368
[TBL] [Abstract][Full Text] [Related]
45. High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort.
Bayigga L; Nabatanzi R; Sekiziyivu PN; Mayanja-Kizza H; Kamya MR; Kambugu A; Olobo J; Kiragga A; Kirimunda S; Joloba M; Nakanjako D
BMC Immunol; 2014 Jan; 15():2. PubMed ID: 24483185
[TBL] [Abstract][Full Text] [Related]
46. Increased Peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK Cell Subset Was Positively Correlated with Antiphospholipid Antibodies in Patients of Obstetric Antiphospholipid Syndrome.
Zhang Y; Zhao Y; Si W; Yang B; Lin M; Zheng J; Cui L
Immunol Invest; 2022 Feb; 51(2):425-437. PubMed ID: 33103514
[TBL] [Abstract][Full Text] [Related]
47. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
[TBL] [Abstract][Full Text] [Related]
48. Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune response.
Frias M; Rivero-Juarez A; Gordon A; Camacho A; Cantisan S; Cuenca-Lopez F; Torre-Cisneros J; Peña J; Rivero A
PLoS One; 2015; 10(3):e0121019. PubMed ID: 25811634
[TBL] [Abstract][Full Text] [Related]
49. Functional restoration of CD56
Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
[TBL] [Abstract][Full Text] [Related]
50. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
[TBL] [Abstract][Full Text] [Related]
51. Emergence of peripheral CD3+CD56+ cytokine-induced killer cell in HIV-1-infected Chinese children.
Fu GF; Chen X; Hu HY; Yang HT; Xu XQ; Qiu T; Li L; Xu JS; Huan XP; Hou YY
Int Immunol; 2012 Mar; 24(3):197-206. PubMed ID: 22281512
[TBL] [Abstract][Full Text] [Related]
52. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
Davis ZB; Cogswell A; Scott H; Mertsching A; Boucau J; Wambua D; Le Gall S; Planelles V; Campbell KS; Barker E
PLoS Pathog; 2016 Feb; 12(2):e1005421. PubMed ID: 26828202
[TBL] [Abstract][Full Text] [Related]
53. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.
Bonorino P; Ramzan M; Camous X; Dufeu-Duchesne T; Thélu MA; Sturm N; Dariz A; Guillermet C; Pernollet M; Zarski JP; Marche PN; Leroy V; Jouvin-Marche E
J Hepatol; 2009 Sep; 51(3):458-67. PubMed ID: 19596474
[TBL] [Abstract][Full Text] [Related]
54. Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection.
Lin SJ; Roberts RL; Ank BJ; Nguyen QH; Thomas EK; Stiehm ER
J Clin Immunol; 1998 Sep; 18(5):335-45. PubMed ID: 9793826
[TBL] [Abstract][Full Text] [Related]
55. Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells.
Hermann E; Alonso-Vega C; Berthe A; Truyens C; Flores A; Cordova M; Moretta L; Torrico F; Braud V; Carlier Y
Pediatr Res; 2006 Jul; 60(1):38-43. PubMed ID: 16690951
[TBL] [Abstract][Full Text] [Related]
56. CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.
Rutjens E; Mazza S; Biassoni R; Koopman G; Ugolotti E; Fogli M; Dubbes R; Costa P; Mingari MC; Greenwood EJ; Moretta L; De Maria A; Heeney JL
Eur J Immunol; 2010 May; 40(5):1440-50. PubMed ID: 20306468
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
[TBL] [Abstract][Full Text] [Related]
58. Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma.
Xu Y; Zhou R; Huang C; Zhang M; Li J; Zong J; Qiu S; Lin S; Chen H; Ye Y; Pan J
Asian Pac J Cancer Prev; 2018 Mar; 19(3):661-665. PubMed ID: 29580037
[TBL] [Abstract][Full Text] [Related]
59. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.
Barcelos W; Sathler-Avelar R; Martins-Filho OA; Carvalho BN; Guimarães TM; Miranda SS; Andrade HM; Oliveira MH; Toledo VP
Scand J Immunol; 2008 Jul; 68(1):92-102. PubMed ID: 18484953
[TBL] [Abstract][Full Text] [Related]
60. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.
Mantegani P; Tambussi G; Galli L; Din CT; Lazzarin A; Fortis C
Immunology; 2010 Feb; 129(2):220-33. PubMed ID: 19824914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
